Comparison of Human Duodenum and Caco-2 Gene Expression Profiles for 12,000 Gene Sequences Tags and Correlation with Permeability of 26 Drugs
暂无分享,去创建一个
Gordon L. Amidon | Duxin Sun | G. Amidon | D. Fleisher | Kyung-Dall Lee | L. Welage | Duxin Sun | David Fleisher | Kyung-Dall Lee | Christopher P. Landowski | Hans Lennernas | Lynda S. Welage | Jeffery L. Barnett | David Foster | C. Landowski | J. L. Barnett | D. Foster | H. Lennernas
[1] M. Fromm,et al. Characterization of the major metabolites of verapamil as substrates and inhibitors of P-glycoprotein. , 2000, The Journal of pharmacology and experimental therapeutics.
[2] J. Crison,et al. A Theoretical Basis for a Biopharmaceutic Drug Classification: The Correlation of in Vitro Drug Product Dissolution and in Vivo Bioavailability , 1995, Pharmaceutical Research.
[3] J. R. Sportsman,et al. Association of intestinal peptide transport with a protein related to the cadherin superfamily. , 1994, Science.
[4] G. Amidon,et al. Human Jejunal Permeability of Two Polar Drugs: Cimetidine and Ranitidine , 2001, Pharmaceutical Research.
[5] H. Melhus,et al. Correlation of gene expression of ten drug efflux proteins of the ATP-binding cassette transporter family in normal human jejunum and in human intestinal epithelial Caco-2 cell monolayers. , 2001, The Journal of pharmacology and experimental therapeutics.
[6] Hitoshi Sezaki,et al. Analysis of Drug Permeation Across Caco-2 Monolayer: Implication for Predicting In Vivo Drug Absorption , 1997, Pharmaceutical Research.
[7] R. Palmer,et al. Cimetidine and ranitidine. Lack of effect on the pharmacokinetics of an acute ethanol dose. , 1993, Journal of clinical gastroenterology.
[8] K. Luthman,et al. Correlation of drug absorption with molecular surface properties. , 1996, Journal of pharmaceutical sciences.
[9] V. Ganapathy,et al. Structural and functional characteristics and tissue distribution pattern of rat OCTN1, an organic cation transporter, cloned from placenta. , 2000, Biochimica et biophysica acta.
[10] G. Amidon,et al. Correlation between epithelial cell permeability of cephalexin and expression of intestinal oligopeptide transporter. , 2001, Journal of Pharmacology and Experimental Therapeutics.
[11] Patrick J. Sinko,et al. Estimating Human Oral Fraction Dose Absorbed: A Correlation Using Rat Intestinal Membrane Permeability for Passive and Carrier-Mediated Compounds , 2004, Pharmaceutical Research.
[12] G. Amidon,et al. Human Intestinal Permeability of Piroxicam, Propranolol, Phenylalanine, and PEG 400 Determined by Jejunal Perfusion , 1997, Pharmaceutical Research.
[13] W. J. Irwin,et al. Suitability of Enalapril as a Probe of the Dipeptide Transporter System: InVitro and In Vivo Studies , 1996, Pharmaceutical Research.
[14] J. Tolan,et al. MDCK (Madin-Darby canine kidney) cells: A tool for membrane permeability screening. , 1999, Journal of pharmaceutical sciences.
[15] Shiew-Mei Huang,et al. Effects of Structural Modifications on the Intestinal Permeability of Angiotensin II Receptor Antagonists and the Correlation of In Vitro, In Situ, and In Vivo Absorption , 1996, Pharmaceutical Research.
[16] T. Tsuruo,et al. The 4F2hc/LAT1 complex transports l-DOPA across the blood–brain barrier , 2000, Brain Research.
[17] G. Amidon,et al. Passive and Carrier-Mediated Intestinal Absorption Components of Two Angiotensin Converting Enzyme (ACE) Inhibitor Prodrugs in Rats: Enalapril and Fosinopril , 1989, Pharmaceutical Research.
[18] S. Stavchansky,et al. Link between drug absorption solubility and permeability measurements in Caco-2 cells. , 1998, Journal of pharmaceutical sciences.
[19] David E. Smith,et al. Competitive Inhibition of Glycylsarcosine Transport by Enalapril in Rabbit Renal Brush Border Membrane Vesicles: Interaction of ACE Inhibitors with High-Affinity H+/Peptide Symporter , 1999, Pharmaceutical Research.
[20] G. Amidon,et al. CHO/hPEPT1 cells overexpressing the human peptide transporter (hPEPT1) as an alternative in vitro model for peptidomimetic drugs. , 1999, Journal of pharmaceutical sciences.
[21] Patrick J. Sinko,et al. Predicting Fraction Dose Absorbed in Humans Using a Macroscopic Mass Balance Approach , 1991, Pharmaceutical Research.
[22] G. Amidon,et al. Intestinal absorption of amino acid derivatives: importance of the free alpha-amino group. , 1982, Journal of pharmaceutical sciences.
[23] Ismael J. Hidalgo,et al. The Role of an α‐Amino Group on H+‐dependent Transepithelial Transport of Cephalosporins in Caco‐2 Cells , 1999 .
[24] P. Augustijns,et al. Evidence for a polarized efflux system in CACO-2 cells capable of modulating cyclosporin A transport. , 1993, Biochemical and biophysical research communications.
[25] G. Amidon,et al. Overexpression of Human Intestinal Oligopeptide Transporter in Mammalian Cells via Adenoviral Transduction , 1998, Pharmaceutical Research.
[26] J. Cunningham,et al. Glucose Transporter Glut3 Is Targeted to Secretory Vesicles in Neurons and PC12 Cells* , 1999, The Journal of Biological Chemistry.
[27] T. Kissel,et al. Prodrug Approach for αΙΙbβ3-Peptidomimetic Antagonists to Enhance Their Transport in Monolayers of a Human Intestinal Cell Line (Caco-2): Comparison of In Vitro and In Vivo Data , 1999, Pharmaceutical Research.
[28] G L Amidon,et al. Caco-2 versus Caco-2/HT29-MTX co-cultured cell lines: permeabilities via diffusion, inside- and outside-directed carrier-mediated transport. , 2000, Journal of pharmaceutical sciences.
[29] M. Yazdanian,et al. Correlating Partitioning and Caco-2 Cell Permeability of Structurally Diverse Small Molecular Weight Compounds , 1998, Pharmaceutical Research.
[30] Andrew Crowe,et al. In Vitro and In Situ Absorption of SDZ-RAD Using a Human Intestinal Cell Line (Caco-2) and a Single Pass Perfusion Model in Rats: Comparison with Rapamycin , 1998, Pharmaceutical Research.
[31] G. Amidon,et al. HT29-MTX/Caco-2 cocultures as an in vitro model for the intestinal epithelium: in vitro-in vivo correlation with permeability data from rats and humans. , 1996, Journal of pharmaceutical sciences.
[32] P. Artursson,et al. Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells. , 1991, Biochemical and biophysical research communications.
[33] H Lennernäs,et al. Human intestinal permeability. , 1998, Journal of pharmaceutical sciences.
[34] M. Kataoka,et al. Optimized conditions for prediction of intestinal drug permeability using Caco-2 cells. , 2000, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[35] Shiyin Yee,et al. In Vitro Permeability Across Caco-2 Cells (Colonic) Can Predict In Vivo (Small Intestinal) Absorption in Man—Fact or Myth , 1997, Pharmaceutical Research.
[36] G. Amidon,et al. Characterization of the Oral Absorption of Some β-Lactams Effect of the α-Amino Side Chain Group , 1993 .
[37] S. Chong,et al. In Vitro Permeability Through Caco-2 Cells is not Quantitatively Predictive of in Vivo Absorption for Peptide-Like Drugs Absorbed via the Dipeptide Transporter System , 2004, Pharmaceutical Research.
[38] D. Jack,et al. CIMETIDINE AND RANITIDINE , 1982, The Lancet.